Showing results (351-360 of 414) with videos related to
Sort By:
Pageof 42
Cancer|December 24, 1997
The growth and maturation of the National Cancer Data BaseH R Menck, M P Cunningham, J M Jessup, et al.Cancer|September 1, 1993
Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection ProjectC Mettlin, G P Murphy, F Lee, et al.Urology|November 9, 2000
Prostate-specific antigen levels in young white and black men 20 to 45 years oldD M Preston, L I Levin, D J Jacobson, et al.The Journal of Urology|November 1, 1994
Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection ProjectC Mettlin, G P Murphy, F Lee, et al.Cancer Research|April 1, 1983
LNCaP model of human prostatic carcinomaJ S Horoszewicz, S S Leong, E Kawinski, et al.Cancer|February 1, 1993
American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigenC Mettlin, G P Murphy, P Ray, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Expression and purification of prostate-specific membrane antigen in the baculovirus expression system and recognition by prostate-specific membrane antigen-specific T cellsP A Lodge, R A Childs, S J Monahan, et al.The Journal of Urology|December 1, 1975
Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized studyW W Scott, D E Johnson, J E Schmidt, et al.Cancer Research|December 1, 1980
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassayM Kuriyama, M C Wang, L D Papsidero, et al.Journal of the National Cancer Institute|February 1, 1986
Relative reliability of five serially measured markers for prognosis of progression in prostate cancerC S Killian, L J Emrich, F P Vargas, et al.Pageof 42